Loading compound...
Thrombin inhibitor
Ximelagatran is an oral small molecule drug that works as a thrombin inhibitor. It was studied for treating conditions like atrial fibrillation and blood clots, but it has been withdrawn from the market due to concerns regarding severe liver injury during long-term use.
How it worksXimelagatran works by inhibiting thrombin, which is an enzyme in the body that helps blood clot.
Used for
Recurrent thrombophlebitisThromboembolismAtrial fibrillation
Conditions
Recurrent thrombophlebitisThromboembolismAtrial fibrillation
Class
Thrombin inhibitorSmall moleculeCardiovascular
How to take
FormsOral
RoutesOral
This drug has been withdrawn from the market in the European Union due to risks of severe liver injury during treatments lasting longer than 11 days.
Key warnings
- ·Severe liver injury may occur during longer-term treatment (more than 11 days).
Side effects
Serious
- ·Severe liver injury
Seek help if
- ·Signs of liver injury
Talk to your doctor
Monitor
- ·Liver function
Questions to ask
- ·Why was this medication withdrawn?
- ·What are the risks of liver injury with blood thinners?
- ·What are the alternatives for treating atrial fibrillation?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
